As OxyContin Falls Out Of Favor In U.S., Purdue Owners Think Global
The Sackler family has become one of the country's wealthiest on the back of the opioid crisis. Now, the family, which owns Purdue Pharma, is looking to push into other countries as efforts to curb the epidemic in the U.S. are gaining traction.
Los Angeles Times:
OxyContin Goes Global — “We’re Only Just Getting Started”
OxyContin is a dying business in America. With the nation in the grip of an opioid epidemic that has claimed more than 200,000 lives, the U.S. medical establishment is turning away from painkillers. Top health officials are discouraging primary care doctors from prescribing them for chronic pain, saying there is no proof they work long-term and substantial evidence they put patients at risk. ... So the company’s owners, the Sackler family, are pursuing a new strategy: Put the painkiller that set off the U.S. opioid crisis into medicine cabinets around the world. (Ryan, Girion and Glover, 12/18)